Loomis, Sayles & Company’s Concentrix CNXC Stock Holding History
Bought
Maintained
Sold
Other funds holding CNXC
KGI
GBL
Loomis, Sayles & Company's CNXC Position: Q2 2026 in Review
Loomis, Sayles & Company reduced its Concentrix (CNXC) stake by 99% in Q2 2026, selling an estimated $547K and leaving 138 shares worth $3.09K. The position accounts for ﹤0.01% of the portfolio, ranked #697.
Loomis, Sayles & Company first reported a position in CNXC in Q4 2020 and has held it in 23 quarters since. The position peaked at $86M in Q4 2021. 271 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.
- Loomis, Sayles & Company held 138 shares of Concentrix worth $3.09K as of Q2 2026.
- Loomis, Sayles & Company sold 20,986 Concentrix shares in Q2 2026, an estimated $547K.
- Concentrix made up ﹤0.01% of Loomis, Sayles & Company's portfolio in Q2 2026, its #697 holding.
- Loomis, Sayles & Company first reported a position in Concentrix in Q4 2020 and has held it in 23 quarters since.
- Loomis, Sayles & Company's Concentrix position peaked at $86M in Q4 2021.
- 271 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.
Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.